Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7.2% year on year to $142 million. On the other hand, next ...
CEO Catherine Corrigan highlighted that Exponent achieved approximately flat revenues in Q1 2025 despite a 5%-6% headwind in technical full-time equivalent employees. Strong demand in reactive ...
Exponent, Inc. announced that it will report its financial results for the second quarter of fiscal year 2025 on July 31, 2025, after market close. Dr. Catherine Corrigan, CEO, and Richard Schlenker, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results